Bio Pharma Dive
DECEMBER 5, 2020
The company plans to submit an approval application to the FDA in the next few weeks, chasing a rival Bristol Myers therapy that's now under review.
World of DTC Marketing
DECEMBER 7, 2020
SUMMARY : According to Harvard Business Review, “digital health solutions and technology will play a crucial role in the difficult work of optimizing processes and systems for greater efficiency, financial viability, and enhanced outcomes. While this is true digital health won’t go anywhere unless there is a renewed effort on the user experience.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
DECEMBER 9, 2020
ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma
BioSpace
DECEMBER 9, 2020
Viruses mutate, and SARS-CoV-2, the virus that causes COVID-19, is not different. Luckily, it appears to mutate relatively slowly. Meanwhile, researchers are beginning to get a grip on the virus’s evolution.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
DECEMBER 5, 2020
Results from 10 patients with beta thalassemia or sickle cell disease show CRISPR Therapeutics and Vertex's pioneering treatment to be effective, building on earlier study data.
World of DTC Marketing
DECEMBER 11, 2020
(Mckinsey) Much of the prevailing market research on COVID-19 vaccination frames sentiment as “likely,” “unlikely,” or “neutral.” McKinsey’s research is designed to uncover a more granular continuum of sentiments and to account for the fact that many consumers may take a “wait and see” approach to their decision about vaccination. Their research has found that consumers’ attitudes towards receiving a COVID-19 vaccine fall into three primary segments.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
DECEMBER 10, 2020
A COVID-19 vaccine being developed by CSL Ltd., and the University of Queensland was scrapped this week after numerous vaccine recipients reported receiving false positives on certain HIV tests.
Bio Pharma Dive
DECEMBER 9, 2020
The U.K.'s RECOVERY trial proved a cheap steroid could keep COVID-19 patients from dying, and showed two other widely considered drugs didn't work — crucial findings in a sprawling and sometimes messy global hunt for coronavirus treatments.
World of DTC Marketing
DECEMBER 8, 2020
SUMMARY: Pharma has been relying on digital agencies for too long but agencies can’t begin to understand your audience like brand team members. Having a brand digital marketer constantly communicating with digital agencies is a waste of time and money. Pharma brands have come to rely too heavily on digital marketing agencies for a range of services, from paid media to actual website development.
Pharma Times
DECEMBER 10, 2020
Updated guidance warns people with a history of allergic reactions not to receive the shot
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
NY Times
DECEMBER 11, 2020
British health officials recommended that people with severe allergy reactions not be given the vaccine. Such reactions to vaccines are rare, even in people who have allergies to food or bee stings.
Bio Pharma Dive
DECEMBER 9, 2020
A panel of vaccine and infectious disease experts will publicly vet the drugmakers' study results on Thursday. Follow the discussion along with BioPharma Dive reporters here.
Camargo
DECEMBER 9, 2020
Remote Document Review Leads to CRL: Be Careful What You Wish for? The FDA’s halt of onsite inspections has created a wealth of problems. Camargo is currently involved with no less than three product applications that are stalled because the FDA is requiring inspections before the application can be approved (assuming a satisfactory outcome). Needless to say, the sponsors of these applications are anxious to pursue all possible alternatives to simply waiting for an indeterminate period for inspe
Pharma Times
DECEMBER 9, 2020
Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards
BioSpace
DECEMBER 8, 2020
The COVID-19 vaccine under development by China’s Sinopharm is showing efficacy of 86%, health authorities from the United Arab Emirates reported this morning.
Bio Pharma Dive
DECEMBER 7, 2020
A pact for two Atara programs continues the German pharma's efforts to use dealmaking to build a gene and cell therapy division.
NY Times
DECEMBER 8, 2020
The Oxford-AstraZeneca effort held great promise to help arrest the pandemic. But a series of miscues caused it to fall behind in the U.S.
Pharma Times
DECEMBER 7, 2020
Around one in five stroke patients could go undiagnosed with the tests currently used by paramedics
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioPharma Reporter
DECEMBER 8, 2020
The US Food and Drug Administration (FDA) said there are âno specific safety concerns that would preclude issuance of an EUAâ for the investigational COVID-19 vaccine (BNT162b2) from US pharma giant, Pfizer, and its German partner BioNTech.
Bio Pharma Dive
DECEMBER 11, 2020
The company created by a merger of Mylan and Pfizer's Upjohn unit is dramatically cutting costs, shedding jobs and closing or divesting up to 15 plants worldwide.
BioSpace
DECEMBER 10, 2020
AstraZeneca, which is jointly developing a COVID-19 vaccine with the University of Oxford, plans to begin clinical trials testing its vaccine in combination with Russia’s Sputnik V vaccine by the end of the year.
Pharma Times
DECEMBER 8, 2020
A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Mirror
DECEMBER 10, 2020
Terrassa (Barcelona) 2020. The Telstar subsidiary in Dhaka, Bangladesh, has relocated to a new installation reacting to the ongoing growth of demand for Life Sciences service & product solutions in the region. Under the leadership of Parvez Hashim, Country General Manager, Telstar’s office has consolidated a professional and specialized service in Asia’s pharmaceutical market in consultancy, engineering, construction and manufacturing processes for development of turnkey plants and installat
Bio Pharma Dive
DECEMBER 11, 2020
The experimental shot produced a weak immune response in adults over 49, leading the partner drugmakers to change plans and push back their development timelines.
pharmaphorum
DECEMBER 9, 2020
COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. CREATION.co’s Lara Meyer explores why HCPs need more support. The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. A key concern that has emerged from the crisis is how COVID-19 will affect other areas of healthcare, particularly cancer diagnosis and treatment.
Pharma Times
DECEMBER 8, 2020
The recommendations are positive for a select population of patients with CLL
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
DECEMBER 9, 2020
Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe from the potential hazardous effects for CO2 exposure from the dry ice that is keeping the COVID-19 vaccines cold. A national pharmacy chain contacted CO2Meter on December 1st asking about devices to detect the release of CO2 when dry ice sublimates.
Bio Pharma Dive
DECEMBER 8, 2020
Two cell therapies might soon be approved for the blood cancer. But a growing group of antibody drugs, several of which were showcased at ASH, aren't far behind.
BioPharma Reporter
DECEMBER 10, 2020
AstraZeneca and the University of Oxford's COVID-19 vaccine candidate threw up a surprise last month when a lower initial dose of the two-dose vaccine showed higher efficacy. More detailed results from this interim analysis, now peer-reviewed and published in The Lancet this week, shed some light on this 'intriguing' efficacy.
Pharma Times
DECEMBER 10, 2020
Submission is based on data from the pivotal SYNAPSE study
Expert insights. Personalized for you.
350 
Let's personalize your content